1542-2011/asset/olbannerleft.jpg?v=1&s=03aeb3354884183388e0706f0541db283703e09f)
1542-2011/asset/olbannerright.jpg?v=1&s=799c7b68ebfed1f051f2fdc92453e2693b34c2e0)
Resources for Clinicians
The New FDA Pregnancy Labeling Requirements for Drugs
Article first published online: 28 APR 2011
DOI: 10.1111/j.1542-2011.2011.00067.x
© 2011 by the American College of Nurse-Midwives
Additional Information
How to Cite
Frederiksen, M. C. (2011), The New FDA Pregnancy Labeling Requirements for Drugs. Journal of Midwifery & Women’s Health, 56: 303–307. doi: 10.1111/j.1542-2011.2011.00067.x
Publication History
- Issue published online: 28 APR 2011
- Article first published online: 28 APR 2011
- Abstract
- Article
- References
- Cited By
Keywords:
- drugs;
- FDA labeling;
- pharmacology pregnancy;
- teratogens;
- US Food and Drug Administration
The new US Food and Drug Administration Proposed Rules for pharmaceutical products for the special population of pregnant women were published in May 2008. With these new rules in place, clinicians caring for women who are pregnant may begin to have clearer and more relevant information in the product label to guide clinical decisions regarding drug use during pregnancy.